Andrew J. Grethlein

Sr VP,Pharmacetical Operations, Tercica.

Companies

Geron CorporationChief operating officer Feb 1, 2019 to now¹
Geron CorporationEVP, Technical Operations Sep 21, 2012 to Feb 2, 2018²
TercicaSr VP,Pharmacetical Operations Mar 14, 2006 to Oct 20, 2008³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Geron Corporation GERN0 shares⁴Jul 8, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 8, 2024Sold 674,348 shares at $4.56 of Geron Corporation⁴
Jul 8, 2024Exercised options 674,348 shares at $1.72 of Geron Corporation⁴
Feb 9, 2023Sold 234,719 shares at $3.03 of Geron Corporation⁵
Feb 9, 2023Sold 150,000 shares at $3.03 of Geron Corporation⁵
Feb 9, 2023Exercised options 150,000 shares at $1.51 of Geron Corporation⁵
Sep 12, 2022Exercised options 232,719 shares at $1.70 of Geron Corporation⁶
Sep 12, 2022Exercised options 2,000 shares at $1.70 of Geron Corporation⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARGeron Corporation, Chief operating officer
2
SEC EDGARGeron Corporation, EVP, Technical Operations
3
SEC EDGARTercica, Sr VP,Pharmacetical Operations
4
SEC EDGARGeron Corporation shares after the filing of Jul 8, 2024
5
SEC EDGARForm 4 filed Feb 10, 2023
6
SEC EDGARForm 4 filed Sep 14, 2022